Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Explore weekend part time jobs that allow you to earn extra money. Take advantage of your free time to enhance your financial situation.
24,225 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A little-known rule may cap a household's Social Security checks when there are dependents. Here’s how the family max...
XRP-linked ETFs attracted $1.77 million in new money, lifting total XRP ETF assets to about $1.12 billion, even as th...
Wealthy Americans are dialing back on flaunting jewelry as market mood shifts. The trend could signal changing demand...
Industry leaders urge a shift from hype to honest storytelling to rebuild trust in reverse mortgages. This report out...
The BEA final read confirms economy grew 2.1% first quarter, signaling momentum. Here’s what drove growth and what ho...
Elon Musk is pursuing a bold plan to run AI data centers in space, backed by SpaceX filings and xAI ambitions. But in...
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Family farms across California warn that energy bills and tighter regulations threaten their livelihoods, with grower...
Bitcoin Depot, once the largest Bitcoin ATM network in North America, filed for Chapter 11 protection and began windi...
Ethereum faces a stubborn test near the $2,000 level as traders weigh on-chain activity and macro signals. A leading ...
Bitcoin trades near a critical threshold as Grayscale signals potential value on-chain. This report weighs whether bi...